Locations:
Search IconSearch
March 11, 2022/Cancer/Surgical Oncology

Hybrid Resection of a Fast-Growing Dumbbell Schwannoma: A Case Study

Two-day procedure prevents neurologic compromise for octogenarian

21-CNR-2573159-CQD-Hero-650×450

An 82-year-old woman presented to Cleveland Clinic with right shoulder pain. An MRI of the spine revealed an incidental left paravertebral mass measuring 4.2 cm in maximal direction. There was extension into the T3 intervertebral foramen with remodeling of the adjacent vertebrae.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Because of the relative lack of symptoms on the left and the patient’s concern about having a major surgery at her age, she consulted with the spine team and decided on observation,” says Daniel Raymond, MD, a thoracic surgeon in the Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic.

A mass can be seen pushing the patient’s spinal cord to the right. The tumor extends through the neuroforamen from the outside and into the spinal canal.

Schwannoma surveillance

During the surveillance period, the patient began to develop pain over her left scapula. She underwent physical therapy, but the pain continued intermittently. Seventeen months after her initial MRI, repeat imaging showed significant extension of the schwannoma into the spinal canal, with compression of the thecal sac and contact with the spinal cord.

“Typically, you wouldn’t expect to see a dramatic change in a schwannoma in only a year or so,” says Dr. Raymond. “In this case, the tumor was pushing on the patient’s spine, causing symptoms and growing relatively quickly.” He and Richard Schlenk, MD, a neurosurgeon and Neurosurgery Residency Training Program Director at Cleveland Clinic, decided that a hybrid resection of the dumbbell-shaped schwannoma was the best course of action.

Surgical solution

Dr. Schlenk performed a T2-3 laminectomy using a standard posterior approach to the spinal component of the paravertebral mass. The following day, Dr. Raymond performed robotic thoracic surgery on the remaining intrathoracic component, encircling and removing the mass located on top of the aorta.

Advertisement

The surgeons opted for a two-day procedure due to the patient’s age and her concerns about the recovery process.

“The stress on the system can be a lot for an octogenarian, so we do the spine surgery first and allow the patient to recover overnight,” explains Dr. Raymond. “This approach gives us an opportunity to medically optimize our patients before putting them through a second significant operation.”

The patient in this case had an uncomplicated postoperative course and was discharged home on day four. Pathology results confirmed a grade 1 spinal schwannoma. Her long-term prognosis is excellent.

Team approach

Dr. Raymond credits the success of the surgery to collaboration among the multidisciplinary team. “We have a great system. It’s not about the individual surgeon: It’s the team and culture,” he says.

Working in tandem, clinicians from thoracic surgery and neurosurgery charted a course to treat the patient based on her physiological status, not her chronological age.

“So often, we see people in our clinic who have been told they are too old for surgery,” says Dr. Raymond. “A person like this patient is clearly a candidate for surgery. We gave her an excellent operation and prevented her from serious neurologic compromise. She did great.”

Advertisement

Related Articles

Dr. Jack Khouri with patient

A Call to Increase Awareness About AL Amyloidosis

New guidelines empower clinicians with practical diagnostic framework

Dr. Shilpa Gupta and patient
April 30, 2026/Cancer/Tumor Oncology

Bladder Cancer Treatment Takes Key Steps Forward

Pivotal Studies Guide Treatment Decisions in Muscle-Invasive Bladder Cancer

Dr. Timothy Gilligan
April 27, 2026/Cancer/Patient Support

Getting Tough Conversations Right in Cancer Care

Reflections from an oncology provider and communications educator on new ASCO Guidelines on Patient-Clinician Communication

p53 mutation illustration
April 22, 2026/Cancer/News & Insight

Study Holds Promise for Targeting Elusive P53 Gene Mutation

Phase 1 trial outcomes offer encouraging news for developing targeted therapy for solid tumors

Synovial sarcoma cells
April 20, 2026/Cancer/News & Insight

T-Cell Receptor Therapy Available for Segment of Population with Synovia Sarcoma

Cleveland Clinic to administer first-of-its-kind T-cell therapy

Dr. Jagadeesh and patient
April 14, 2026/Cancer/News & Insight

Bispecific Antibody Shows Deep Remission in Patients with Relapsed/Refractory Follicular Lymphoma

Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy

Endoscopic nipple-sparing mastectomy

Case Study: Endoscopic Nipple-Sparing Bilateral Mastectomy Improves Outcomes

Innovative procedure reduces scarring, recovery time and nipple sensation

Doctor comforting patient
April 1, 2026/Cancer/News & Insight

What Gets in the Way of End-of-Life Care Discussions?

Best practices for supporting patients with honesty and compassion

Ad